article Open AccessTop 1% cited
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
The Lancet Oncology · 2009 · Vol. 11(1) · pp. 55–65
Kathy S. Albain✉(Loyola University Chicago)William E. Barlow(SWOG Cancer Research Network)Steven Shak(Genomic Health (United States))Gabriel N. Hortobágyi(The University of Texas MD Anderson Cancer Center)Robert B. Livingston(University of Arizona)I‐Tien Yeh(The University of Texas Health Science Center at San Antonio)Peter M. Ravdin(The University of Texas Health Science Center at San Antonio)Roberto Bugarini(Genomic Health (United States))Frederick L. Baehner(Genomic Health (United States))Nancy E. Davidson(UPMC Hillman Cancer Center)George W. Sledge(University Medical Center)Eric P. Winer(Dana-Farber Cancer Institute)Clifford A. Hudis(Memorial Sloan Kettering Cancer Center)James N. Ingle(Mayo Clinic in Florida)Edith A. Perez(Jacksonville College)Kathleen I. Pritchard(Sunnybrook Health Science Centre)Lois E. Shepherd(Queen's University)Julie R. Gralow(Seattle Cancer Care Alliance)Carl Yoshizawa(Genomic Health (United States))D. Craig Allred(Washington University in St. Louis)C. Kent Osborne(Baylor College of Medicine)Daniel F. Hayes(University of Michigan–Ann Arbor)
Breast Cancer Treatment StudiesBreast Lesions and CarcinomasHER2/EGFR in Cancer ResearchTamoxifenMedicineInternal medicineBreast cancerOncologyHazard ratioProportional hazards modelAnthracyclineChemotherapyCyclophosphamide
MeSH terms
AdultAgedAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCyclophosphamideDoxorubicinFemaleFluorouracilGenetic TestingHumansLymphatic MetastasisMiddle AgedPredictive Value of TestsReceptors, EstrogenRecurrence
Funding
- U.S. Department of Health and Human Services
- Genomic Health
- National Cancer Institute
Citations
1,391
FWCI
28.46
field-weighted impact
References
37
Percentile
100%
vs. same field & year
Citations per year
Cited by
Effects of Age on the Detection and Management of Breast Cancer
Cancers · 2015 · 374 citations
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Clinical Cancer Research · 2010 · 818 citations
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
European Journal of Cancer · 2017 · 527 citations
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Annals of Oncology · 2013 · 3,672 citations
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2010 · 2,860 citations
Breast Cancer Treatment
JAMA · 2019 · 4,716 citations
References
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
The Lancet · 2005 · 7,586 citations
REporting recommendations for tumour MARKer prognostic studies (REMARK)
British Journal of Cancer · 2005 · 1,372 citations
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
New England Journal of Medicine · 2004 · 6,318 citations
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
Journal of Clinical Oncology · 2007 · 2,211 citations
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study
Breast Cancer Research and Treatment · 2008 · 297 citations
Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
Statistics in Medicine · 2002 · 1,490 citations
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
Annals of Oncology · 2009 · 1,367 citations
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
Annals of Oncology · 2007 · 939 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.